Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
Clinical trial NCT07113743 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07113743
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-10
- Primary completion
- 2028-09-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.